Skip to main content

Future cancer

Inquiry

The Future Cancer inquiry will explore innovations in cancer diagnosis and treatment.

It will look at the innovations with the greatest potential to transform cancer diagnosis and treatment for patients in the short, medium and long term, and it will examine how innovations in diagnosing and treating cancer can best be transitioned into frontline clinical settings. It will also explore international examples of best practice.

Types of innovations that could be examined by the inquiry range from medicines and vaccines to artificial intelligence. 

This inquiry builds on the Committee's recent work on cancer services, including its report in April 2022, which was focused largely on current provision of cancer services and the impact of the covid-19 pandemic.

 

 

This inquiry is no longer accepting evidence

The deadline for submissions was Wednesday 26 April 2023.

Reports, special reports and government responses

No reports or special reports published.

Chair to Secretary of State for Health and Social Care on Future Cancer 23.05.24
Inquiry Future cancer
Correspondence

Oral evidence transcripts

View all oral evidence transcripts
29 January 2024
Inquiry Future cancer
Oral Evidence
9 January 2024
Inquiry Future cancer
Oral Evidence
28 November 2023
Inquiry Future cancer
Oral Evidence
Boehringer Ingelheim Ltd (FCR0088)
Dr Paul Mulholland (Honorary Associate Professor at University College London) (FCR0087)
Maggie's (FCR0085)

Other publications

No other publications published.

Contact us

We can't usually help you with an individual problem or a specific complaint.

  • Email: hsccom@parliament.uk
  • Phone: (general enquiries) 020 7219 6182 | 020 7219 3138 (media enquiries)
  • Address: Health and Social Care Committee, House of Commons, London, SW1A 0AA